Cargando…
Downregulation of reticulocalbin‐1 differentially facilitates apoptosis and necroptosis in human prostate cancer cells
Reticulocalbin 1 (RCN1), an endoplasmic reticulum (ER)‐resident Ca(2+)‐binding protein, is dysregulated in cancers, but its pathophysiological roles are largely unclear. Here, we demonstrate that RCN1 is overexpressed in clinical prostate cancer (PCa) samples, associated with cyclin B, not cyclin D1...
Autores principales: | Liu, Xiaofei, Zhang, Nianzhao, Wang, Dawei, Zhu, Deyu, Yuan, Quan, Zhang, Xiulei, Qian, Lilin, Niu, Huanmin, Lu, Yi, Ren, Guijie, Tian, Keli, Yuan, Huiqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5891187/ https://www.ncbi.nlm.nih.gov/pubmed/29453900 http://dx.doi.org/10.1111/cas.13541 |
Ejemplares similares
-
Reticulocalbin-1 Facilitates Microglial Phagocytosis
por: Ding, Ying, et al.
Publicado: (2015) -
Hyper‐acetylation contributes to the sensitivity of chemo‐resistant prostate cancer cells to histone deacetylase inhibitor Trichostatin A
por: Xu, Qingqing, et al.
Publicado: (2018) -
Reticulocalbin 3 Is a Novel Mediator of Glioblastoma Progression
por: He, Yi, et al.
Publicado: (2023) -
Reticulocalbin 2 as a Potential Biomarker and Therapeutic Target for Atherosclerosis
por: Li, Jing, et al.
Publicado: (2022) -
Proteasome inhibition boosts autophagic degradation of ubiquitinated-AGR2 and enhances the antitumor efficiency of bevacizumab
por: Wang, Dawei, et al.
Publicado: (2019)